<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ep-patent-document PUBLIC "" "ep-patent-document-v1-0.dtd">
<ep-patent-document lang="en" file="St36_CZ_305523_B6.xml"
	country="CZ" doc-number="305523" kind="B6">
	<bibliographic-data country="CZ">
		<publication-reference>
			<document-id>
				<country>CZ</country>
				<doc-number>305523</doc-number>
				<kind>B6</kind>
				<date>20151118</date>
			</document-id>
		</publication-reference>
		<classifications-ipcr>
			<classification-ipcr sequence="1">
				<text>C07D 491/044 20060101AFI20060521RMWO        </text>
			</classification-ipcr>
			<classification-ipcr sequence="2">
				<text>C07D 491/04 20060101ALI20051008RMEP        </text>
			</classification-ipcr>
			<classification-ipcr sequence="3">
				<text>C07D 491/00 20060101ALI20061125RMEP        </text>
			</classification-ipcr>
			<classification-ipcr sequence="4">
				<text>A61P 35/00 20060101ALI20060521RMWO        </text>
			</classification-ipcr>
			<classification-ipcr sequence="5">
				<text>A61K 31/38 20060101ALI20150825BHCZ        </text>
			</classification-ipcr>
		</classifications-ipcr>
		<application-reference>
			<document-id>
				<country>CZ</country>
				<doc-number>2003-418</doc-number>
				<date>20010801</date>
			</document-id>
		</application-reference>
		<language-of-filing>cs</language-of-filing>
		<language-of-publication>cs</language-of-publication>
		<priority-claims>
			<priority-claim sequence="1" kind="international">
				<country>US</country>
				<doc-number>2000 225590</doc-number>
				<date>20000816</date>
			</priority-claim>
		</priority-claims>
		<parties>
			<applicants>
				<applicant sequence="1" designation="all" app-type="applicant">
					<addressbook>
						<orgname>BRISTOL-MYERS SQUIBB COMPANY</orgname>
						<address>
							<street>P.O.Box 4000, Lawrenceville-Princeton Road</street>
							<city>08543-4000 Princeton</city>
							<country>US</country>
						</address>
					</addressbook>
					<nationality>
						<country>US</country>
					</nationality>
					<residence>
						<country>US</country>
					</residence>
				</applicant>
			</applicants>
			<inventors>
				<inventor sequence="1" designation="all">
					<addressbook>
						<last-name>Dimarco</last-name>
						<first-name>John D.</first-name>
						<address>
							<street>16 Neal Dr.</street>
							<city>08816 East Brunswick</city>
							<country>US</country>
						</address>
					</addressbook>
				</inventor>
				<inventor sequence="2" designation="all">
					<addressbook>
						<last-name>Gougoutas</last-name>
						<first-name>Jack Z.</first-name>
						<address>
							<street>101 Westerly Rd.</street>
							<city>08540 Princeton</city>
							<country>US</country>
						</address>
					</addressbook>
				</inventor>
				<inventor sequence="3" designation="all">
					<addressbook>
						<last-name>Vitez</last-name>
						<first-name>Imre M.</first-name>
						<address>
							<street>117 Main St.</street>
							<city>08889 Whitehouse Station</city>
							<country>US</country>
						</address>
					</addressbook>
				</inventor>
				<inventor sequence="4" designation="all">
					<addressbook>
						<last-name>Davidovich</last-name>
						<first-name>Martha</first-name>
						<address>
							<street>159 Fern Rd.</street>
							<city>08816 East Brunswick</city>
							<country>US</country>
						</address>
					</addressbook>
				</inventor>
				<inventor sequence="5" designation="all">
					<addressbook>
						<last-name>Galella</last-name>
						<first-name>Michael</first-name>
						<address>
							<street>3 Evergreen Ct.</street>
							<city>08502 Belle Mead</city>
							<country>US</country>
						</address>
					</addressbook>
				</inventor>
				<inventor sequence="6" designation="all">
					<addressbook>
						<last-name>Malloy</last-name>
						<first-name>Timothy M.</first-name>
						<address>
							<street>1902 Makefield Rd.</street>
							<city>19067 Yardley</city>
							<country>US</country>
						</address>
					</addressbook>
				</inventor>
				<inventor sequence="7" designation="all">
					<addressbook>
						<last-name>Guo</last-name>
						<first-name>Zhenrong</first-name>
						<address>
							<street>21 Augusta Place</street>
							<city>08816 East Brunswick</city>
							<country>US</country>
						</address>
					</addressbook>
				</inventor>
				<inventor sequence="8" designation="all">
					<addressbook>
						<last-name>Favreau</last-name>
						<first-name>Denis</first-name>
						<address>
							<street>5065 Terrase Beaudry, Saint-Hubert</street>
							<city>J3Y 6L2 Quebec</city>
							<country>CA</country>
						</address>
					</addressbook>
				</inventor>
			</inventors>
			<agents>
				<agent sequence="1" rep-type="agent">
					<addressbook>
						<last-name>Kalenský</last-name>
						<first-name>Petr</first-name>
						<address>
							<street>Hálkova 2</street>
							<city>Praha 2</city>
							<postcode>12000</postcode>
							<country>CZ</country>
						</address>
					</addressbook>
				</agent>
			</agents>
		</parties>
		<invention-title lang="CS">Krystalický polymorf analogu
			epothilonu, způsob jeho výroby, farmaceutický přípravek s aktivní
			složkou tohoto polymorfu a použití tohoto polymorfu k výrobě léčiva</invention-title>
		<invention-title lang="EN">Polymorphs of epothilone analogs </invention-title>
		<references-cited>
			<citation>
				<patcit id="pcit0001" dnum="WO9942602" dnum-type="publication number">
					<text>(Novartis Erfind Verwalt), 26.8.1999, str. 1, 10,17,24,25,
						nároky, anotace</text>
				</patcit>
			</citation>
			<citation>
				<patcit id="pcit0002" dnum="WO9927890" dnum-type="publication number">
					<text>(Squibb bristol Myers CO), 10.6.1999, str. 1,5, př. 1, nároky
						, anotace</text>
				</patcit>
			</citation>
		</references-cited>
	</bibliographic-data>
	<abstract lang="CS">
		<p num="1">﻿Krystalické polymorfy analogu epothilonu představovaného
			obecným vzorcem I, označené jako forma A a forma B v uvedeném pořadí,
			stejně jako jejich směsi. Způsob výroby nových polymorfů, použití
			uvedených krystalických polymorfů k výrobě léčiva pro léčby, které je
			využívají, a farmaceutické dávkovací formy, které je obsahují.
		</p>
	</abstract>
	<abstract lang="EN">
		<p num="1">There are provided in accordance with the present invention
			two crystalline polymorphs, designated Form A and Form B,
			respectively, as well as mixtures thereof, of an epothilone analog
			represented by formula (I). Also provided are methods of forming the
			novel polymorphs, therapeutic methods utilizing them and
			pharmaceutical dosage forms containing them.
		</p>
	</abstract>
</ep-patent-document>
